LONDON, Aug. 20 /CNW/ - Logos Technologies, Inc. is holding its 2nd
Annual face-to-face 'ALPHADAS(R) User Group' (AUG) meeting in October 2009,
hosted by Spaulding Clinical Research at their comprehensive, leading Phase I
Clinical trial facility.
"I am excited to host the AUG and to showcase our fully-automated,
state-of-the-art clinic using ALPHADAS(R)," said Daniel Selness, Vice
President of Operations at Spaulding Clinical and President of the AUG. "We
have automated our site by seamlessly integrating ALPHADAS(R) with a host of
systems, including Dynacare Laboratory and Mortara's Surveyor 12-Lead Wireless
ECG for near real-time electronic results," continued Mr. Selness.
For more information on Spaulding Clinical, watch their video tour and
see ALPHADAS(R) in action at their website: http://www.spauldingclinical.com
"We are very excited about this year's event and are expecting an
excellent turnout of ALPHADAS(R) users - which should include two of the top
ten pharmaceuticals - plus Duke Clinical Research Unit, and a number of other
key organizations," said Jason Straber, Vice President of Logos Technologies,
Inc. Jason is assisting in the facilitation of this year's event.
The AUG meeting will be an excellent opportunity for users to experience
a fully-automated site, listen to presentations, share experiences, network
with peers, and learn about industry developments and the technology roadmap.
Logos Technologies, Inc. will be introducing a wide range of services to
accelerate implementations for new clients, accelerate timelines to upgrade
existing clients, and offer operational support, such as study design and
planning efforts within ALPHADAS(R).
"We are pleased to announce that despite the recent internal changes
within the Logos group, Logos Technologies Inc. now has the opportunity to
provide our clients with an even higher level of service. We believe this will
position us as a leader in Early Phase EDC and Phase I site automation," said
Giles Wilson, CEO of Logos Technologies, Inc. "Additionally, the imminent
launch of our new client partnership program will add more value to our early
Phase products and services, which, in turn, will bring great success and
value to our clients and our marketplace."
About Logos Technologies Inc.
Logos Technologies Inc is a leading provider of world-class integrated
clinical trial solutions to the industry's pharmaceutical, biotechnology and
clinical research organisations. ALPHADAS(R) is an early Phase clinical trials
system that is mobile, schedule-driven, and that provides proactive real-time
eSource data collection.
For further information:
For further information: Angela King at email@example.com or
go to http://www.logostechnologies.com, +44 (0)8707 478900